Big pharma's efforts to market drugs and vaccines in China and its related challenges have come up in recent quarterly earnings calls, and next month's issue will delve into possible ramifications this could have for the future. Also, the May issue will include the latest on European data regulations, obesity drug compounders and more.
Next Issue
May 2025
Don’t miss out – sign up to our free industry-leading magazine and newsletters
EDITORIAL
Editor |Manasi Vaidya
Deputy Editor | Ross Law
Writers | Abigail Beaney, Akosua Mireku, Frankie Fattorini, Irena Maragkou, Jenna Philpott
Graphic Designers | Anett Arc, Noemi Balint, Will Ingham, Miriam Garofalo
ADVERTISING
Sales Manager | Tom McCormick
+44 207 8669440
Copyright 2025 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.